Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Blue Razz: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)

Extract Labs, INC. recalled Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Aug 26, 2025.

The FDA-published reason for this recall is: "Potential peanut protein cross-contact."

Distribution was broad: the FDA record describes it as "Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Lafayette, CO. The recall covers 19,810 gummies of product. The FDA has Terminated this recall (first reported Oct 1, 2025), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.